Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study-Reference-Cited by-同舟云学术

Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study

Published:2022-10-10 Issue:11 Volume:15 Page:2744-2757
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Na Joo Young¹^ORCID,Yoon Deok Yong¹^ORCID,Yoo Hyounggyoon²^ORCID,Lee SeungHwan¹^ORCID,Yu Kyung‐Sang¹^ORCID,Jang In‐Jin¹,Yoo Sang‐Ku³,Kim Youngah³,Oh Jaeseong¹^ORCID

Affiliation:

1. Department of Clinical Pharmacology and Therapeutics Seoul National University College of Medicine and Hospital Seoul Korea

2. Department of Clinical Pharmacology and Therapeutics, CHA Bundang Medical Center Seongnam Korea

3. Glaceum Incorporated Suwon Korea

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13401

Reference33 articles.

1. The genetics of obesity: from discovery to biology

2. Overweight and Obesity: Prevalence, Consequences, and Causes of a Growing Public Health Problem

3. Overweight and obesity

4. Obesity: global epidemiology and pathogenesis

5. Obesity in adults: a clinical practice guideline

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of meal type on the bioavailability of vutiglabridin, a novel anti‐obesity agent, in healthy subjects;Clinical and Translational Science;2024-03

2. Prenylated flavonoid fractions from Glycyrrhiza glabra alleviate insulin resistance in HepG2 cells by regulating the ERK/IRS-1 and PI3K/Akt signaling pathways;Archives of Pharmacal Research;2024-01-24

3. Discovery of Ingenane Diterpenoids from Euphorbia hylonoma as Antiadipogenic Agents;Journal of Natural Products;2023-11-17